Type2diabetes
101
30
37
41
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 101 trials
100.0%
+13.5% vs benchmark
11%
11 trials in Phase 3/4
10%
4 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 41 completed trials
Clinical Trials (101)
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes
Integrating a Prescription Produce Program Within a Diabetes Prevention Program
Use of taVNS for Painful Diabetic Neuropathy: 12-Week Randomized, Sham-Controlled Trial
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
CGM Experience, Preferences & Blood Glucose Parameters
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
The Bennett Kids PowerUP Project
The Effects of Glucagon on Hepatic Metabolism
TRE in Type 2 Diabetes (See Food Study 3)
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
NAD Augmentation in Diabetes Kidney Disease
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Finerenone and Renal Oxidative Stress